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doi:10.1016/j.ejvs.2010.01.017Abstract Objectives: Acute superior mesenteric artery (SMA) occlusion can be diagnosed in
an early phase by computed tomography (CT) angiography, which is also a prerequisite for
endovascular intervention. However, the issue of development of postoperative permanent
renal failure due to contrast-induced nephropathy has not been evaluated.
Design: Retrospective
Materials: A total of 55 patients with acute SMA occlusion were retrieved from the in-hospital
register during a 4-year period between 2005 and 2009.
Methods: Glomerular filtration rate was calculated as a simplified variant of Modification of
Diet in Renal Disease Study Group (MDRD).
Results: Preoperative renal insufficiency was found in 52%; advanced state in one patient.
Creatinine was lower (p Z 0.018) at discharge (median: 71 mmol Le1), compared to admission
(median: 76 mmol Le1), in the 32 survivors exposed to repeated iodinated contrast media
(median: 54.7 g iodine). No patient died due to renal failure or needed dialysis after endovas-
cular intervention. Endovascular intervention was associated with a higher survival rate
(p Z 0.001).
Conclusion: Serious acute contrast-induced nephropathy was not found in patients diagnosed
by CT angiography and treated by endovascular procedures for acute SMA occlusion. Elevated
serum creatinine levels should not deter the clinician from ordering a CT angiography in
patients with suspicion of acute SMA occlusion.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.33 8097.
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Nephropathy after Intervention for Acute SMA Occl 727Acute thrombo-embolic occlusion of the superior mesen-
teric artery (SMA) is one of the most lethal diseases in
patients with acute abdomen. Recent developments in
computed tomography (CT) technology1 have made it
possible to diagnose this condition early, allowing time for
mesenteric revascularisation. Indeed, a variety of acutely
planned endovascular techniques have been developed
from the information gathered from the CT angiography
images.2 CT examination without use of intravenous
contrast enhancement is associated with diagnostic delay
and increased mortality.1 However, there are concerns
regarding contrast-induced nephropathy (CIN) in these
often elderly patients with concurrent cardiovascular
disease undergoing both CT angiography and conventional
angiography for treatment. Indeed, serum creatinine as
a risk indicator is usually required by the radiologists prior
to CT examination. There is a risk that patients with acute
SMA occlusion may be disqualified for a proper CT angiog-
raphy by the radiologists due to an elevated serum creati-
nine alone. In fact, it is not unlikely that elevated
creatinine is common in these patients at admission due to
the occurrence of dehydration, vomitus, diarrhoea, accu-
mulation of fluid in the intestinal lumen and bowel wall
oedema. The risk of CIN3 and permanent kidney damage
may be high in patients diagnosed with acute SMA occlu-
sion, who undergo both diagnostic CT angiography and
therapeutic angiography. The main aim of the present study
was to assess renal function before and after exposure to
iodinated contrast media in patients undergoing endovas-
cular intervention for acute SMA occlusion.
Patients and Methods
The primary catchment population was approximately
756 000 inhabitants (Swedish Central Bureau of Statistics;
http://www.scb.se). The records of patients with diagnosis
of acute SMA occlusion during a 4-year period between 1
November 2005 and 31 October 2009 were retrieved
through a combined search of a local endovascular data-
base and the in-hospital registry of Malmo¨ University
Hospital. The diagnosis of acute SMA occlusion (nZ 55) was
established after CT scan with intravenous contrast
enhancement at initial or at re-evaluation in all but one
patient, who was diagnosed at laparotomy.
Definitions
Glomerular filtration rate (GFR) was calculated as a simpli-
fied variant of Modification of Diet in Renal Disease
Study Group (MDRD).4 All patients were white Caucasians
and advanced renal insufficiency was defined as
GFR < 25 mL mine1. Renal insufficiency by serum creatinine
levels alone was defined as serum creatinine level
>105 mmol Le1 in men and creatinine >90 mmol Le1 in
women. The iodine (I) (g)/GFR (mL mine1) ratio at admis-
sion is an estimate for the risk of developing contrast-
medium-induced nephropathy, and I-dose/GFR ratio 1.0
is considered to be a threshold value for a clear risk.5
Hypertension was defined as a systolic pressure exceeding
140 mmHg or a diastolic pressure exceeding 90 mmHg
measured at least at two different occasions, a history ofhypertension or treatment with anti-hypertensive medica-
tion. Ischaemic heart disease included previous myocardial
infarction, angina pectoris or coronary intervention. Stroke
included cerebral infarction or transitory ischaemic attack
(TIA). The onset of abdominal pain was divided into acute
(within 1 h) or insidious (more than 1 h). The nature of
occlusion, embolic or thrombotic, was based on radiological
findings at CT angiography and/or angiography, and/or
clinical, surgery and/or autopsy data.
Statistical methods
Data management and statistical analysis were performed
using SPSS for Windows, version 17.0 (SPSS, Chicago, IL,
USA). Differences in proportions were analysed using
chi-square or Fisher’s exact test. Continuous variables were
expressed in median and interquartile range (IQR), and
differences were evaluated using ManneWhitney U or
Wilcoxon tecken-rang test. P < 0.05 was considered
significant.
Results
Patient characteristics
Median age was 76 years (IQR: 67e84) and the proportion of
women was 78% (43/55). The prevalence of hypertension
was 50%, diabetes mellitus 18%, claudication 34%, stroke or
transient ischaemic attack 14%, ischaemic heart disease
31% and previous vascular surgery 29%. The nature of
occlusion was embolic in 53% and thrombotic in 47% of the
cases. Synchronous emboli (n Z 23) were found in 14/29
(48%) patients with embolic occlusion, and these were
dislodged to the kidney (nZ 11), leg (nZ 5), arm (nZ 2),
spleen (n Z 2), coeliac trunk (n Z 2) and cerebellum
(n Z 1). Eight patients had renal emboli, of whom three
had bilateral. Patients with atherosclerotic and acute
thrombotic occlusive disease (n Z 26), verified by CT
angiography (n Z 26) and/or angiography (n Z 21), had
either an SMA occlusion (n Z 16) or an SMA stenosis
(n Z 10). The coeliac trunk was occluded in nine, stenotic
in 14 and showed no significant stenosis in three patients.
Symptoms and signs
Symptom duration from the onset of disease to proper
treatment was 47 h (IQR: 24e120) in patients with embolic
versus 312 h (IQR: 48e720) for those with thrombotic
occlusion (p Z 0.001). Onset of disease was acute in 27
(49%) and insidious in 28 (51%) of patients, respectively.
Vomitus occurred in 73% and diarrhoea in 55% of the
patients on admission.
Treatment for acute embolic SMA occlusion
The following main procedures for embolic occlusion
(nZ 29) were performed: open SMA embolectomy (nZ 8),
endovascular aspiration SMA embolectomy from the groin
(n Z 9), endovascular mechanical fragmentation of
embolus with Rotarex (Straub-Medical AG, Wangs,
Figure 1 Creatinine values at admission and at discharge
after endovascular intervention for acute SMA occlusion in 32
patients. Box plot graph showing median values and IQRs of
creatinine. Line across the box indicate the median, the box
represents IQR, and the whiskers are lines that extend from the
box edge to the highest and lowest values, excluding outliers
andC extremes). A significant decrease (p Z 0.018) in creat-
inine values was found. Note the decreased variability of
creatinine values at discharge.
728 S. Acosta et al.Switzerland) (n Z 2) or AngioJet Ultra (MEDRAD Inter-
ventional/Possis, Minneapolis, MN, USA) (n Z 1) devices.
Intra-arterial thrombolysis with 39.5 mg of alteplase
(Actilyse; Boehringer Ingelheim, Stockholm, Sweden) was
administered locally for massive leg embolisation in one
patient with a CT-verified embolic SMA occlusion as well.
The patient had severe leg ischaemia but was apparently
asymptomatic from the abdomen. After successful throm-
bolysis for leg emboli, control angiography of the SMA
showed that the embolus was totally dissolved. Adjunctive
intra-arterial thrombolysis in the SMA was performed in five
patients. Three primary bowel resections were performed,
one after a failed endovascular procedure causing a long
dissection in the SMA. Conservative treatment with full
dose of low-molecular-weight heparin resulted in slow
resolution of abdominal symptoms and discharge in
a 92-year-old woman. One patient underwent explorative
laparotomy only. Palliative treatment without explorative
laparotomy was performed in three patients. Two patients
were converted from an open to endovascular procedure.
Treatment for acute thrombotic SMA occlusion
For thrombotic occlusion (n Z 26), the following main
procedures were performed: stenting of the SMA (n Z 18),
thrombolysis of an acutely thrombosed stent in the SMA,
followed by re-stenting (n Z 1), percutaneous angioplasty
(PTA; n Z 1) and primary bowel resection (n Z 2). One
patient underwent a diagnostic angiography only, which
showed peripheral occlusive lesions in the SMA, considered
difficult-to-treat endovascular, and this patient was
therefore treated with bowel resection. Three patients
were managed by palliative treatment without explorative
laparotomy. The endovascular interventions were preceded
by access through the brachial (n Z 11), femoral (n Z 13)
and intra-abdominal SMA (n Z 6) route. SMA stenting was
performed from an antegrade (n Z 16) or intra-abdominal
retrograde approach (n Z 3). The stented occlusive
lesions of the SMA (n Z 19) were treated by stentgrafts
(n Z 4), balloon-expandable stents (n Z 13) and self-
expandable stents (n Z 13). Three patients were con-
verted from endovascular to an open vascular procedure.
Pre- and postoperative renal function
Median GFR at admission was 60.5 mL mine1 (IQR:
42.0e83.5). One patient was classified as having an
advanced renal insufficiency. According to serum creatinine
values alone, renal insufficiency was found in 52% (28/54).
The median creatinine level at admission in 32 survivors
undergoing endovascular intestinal revascularisation or
angiography-assisted open vascular procedure was
76 mmol Le1 (IQR: 63e114; range: 44e169). These patients
were first exposed to 27 g of iodinated contrast media
during the CT angiography scan, and then to another 27.7 g
iodine (IQR: 20.9e49.8) iodine during the angiography
series. One patient underwent carbon dioxide angiography,
supplemented with 4.0 g iodine. The prevalence of I-dose/
GFR ratio 1.0 at admission was 14/32 (44%). The median
creatinine level at discharge, compared to admission
levels, was lower, 71 mmol Le1 (IQR: 60e81) (p Z 0.018).The comparative creatinine values at admission and at
discharge in these patients are displayed with a box plot
graph (Fig. 1). The patient with an outlier value at
discharge, 110 mmol Le1, 15 days postoperatively,
compared to 93 mmol Le1 at admission, had a creatinine
value of 82 mmol Le1 2 months postoperatively. The patient
with an extreme value at discharge, 156 mmol Le1, 8 days
postoperatively, compared to 84 mmol Le1 at admission, had
a creatinine value of 123 mmol Le1 2 months post-
operatively. The median creatinine at admission for the five
survivors with diabetes mellitus who underwent endovas-
cular intervention was 114 mmol Le1, compared to
76 mmol Le1 at discharge (p Z 0.50). Four patients with
emboli to the kidneys survived after endovascular inter-
vention, of whom two had bilateral emboli: the median
creatinine values at admission and discharge were
120 mmol Le1 and 76 mmol Le1, respectively (pZ 0.27). One
of those four patients had an increase in creatinine from
107 to 154 mmol Le1 at discharge. No study patient died due
to renal failure or needed dialysis after endovascular
intervention.
In-hospital mortality
In-hospital mortality was 33% (18/55). Compared to the
whole study group, successful intestinal revascularisation
(n Z 37) and attempting endovascular intervention
(nZ 29) were associated with lower mortality rates of 11%
(p < 0.001) and 17% (p Z 0.001), respectively. Perfor-
mance of bowel resection (p Z 0.20) and check/second-
look laparotomy (p Z 0.064) resulted in a mortality of
44% (8/18) and 48% (10/21), respectively. Six out of 35
patients died after attempting endovascular or hybrid
intervention: the death causes were intestinal infarction
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(n Z 1) and pneumonia (n Z 1). Survival according to
treatment performed is summarised in Fig. 2.Discussion
More than 50% of the study patients had preoperative renal
insufficiency. Elevated serum creatinine at admission is,
however, seldom caused by a known renal insufficiency
disorder among patients with acute SMA occlusion.1
Instead, the increase in creatinine reflects a state of
dehydration. In addition, the study patients often had
various risk factors for developing CIN3 such as old age,
atrial fibrillation and cardiac failure. The radiologists are
very aware of CIN, which is reported to occur in a dose-
dependent manner in an inverse relation to the patient’s
GFR. However, CT angiography is not only the best diag-
nostic tool in patients with acute SMA occlusion, but it may
also diagnose the nature of vascular pathology for better
operative planning. When a diagnosis is established by CT
angiography, there is rarely any obvious contraindication to
endovascular treatment, even if there is an inherent
increased risk of nephropathy after repeat intra-arterial
contrast media injections above the renal arteries.6
Somewhat unexpectedly, creatinine was significantly
lower at discharge than at admission in the 32 survivors
undergoing intestinal revascularisation, despite an I-dose/
GFR ratio 1.0 in 44% and repeated exposures of iodinated
contrast media by the intravenous and then the intra-
arterial route during CT and angiography series, respec-
tively. Furthermore, patients with concomitant emboli to
the kidneys should be regarded as extreme high-risk
patients for developing severe renal failure; however,
only one study patient had an increase of creatinine values
during hospital stay. In fact, renal function dynamics with
a decreased creatinine at discharge after a similar iodin-
ated contrast dose exposure has also been observed in
survivors after endovascular repair of ruptured abdominalPatients with acute SM
occlusion 
n= 55 
No 
intervention 
n = 6 
Explorative 
laparotomy only 
n= 1 
Survival (%)          0 (0)           0 (0)            1 (100)  
Medical 
intervention 
n=1
Figure 2 Management and survival of patients with acute SMA
endovascular surgery. Performance of bowel resection was per
respectively.aortic aneurysm.7 The incidence and serious consequences
of administrated intravenous iodinated contrast seem to be
much less common than previously thought of.8 In fact,
most episodes of CIN are self-limited, resolving within 1e2
weeks, and seldom leads to permanent kidney damage. One
case-control study has shown that CT angiography did not
increase the risk for acute nephropathy.9 Of note, no study
patient died due to renal failure or needed dialysis after
endovascular intervention. Similar results have been
reported in 301 high-risk patients for contrast-medium-
induced nephropathy, with GFR <60 mL mine1, under-
going multidetector row CT with intravenous iodinated
contrast, where no cases of acute renal failure requiring
specific medical treatment or haemodialysis were
observed.10
Preventive measures should be taken, however, to
reduce the incidence of CIN. In an emergency situation,
intravenous rehydration with isotonic saline solution, at
least 1 mL kge1 body weight per hour, before and after each
iodinated contrast media exposure is most important.
Second, a reduction in contrast dose without compromising
imaging quality may be feasible in patients with low flow
states and in skinny individuals.11 Esteban et al. have
suggested the use of 30 mL 1.0 M gadobutrol as contrast
medium for CT aortography in patients with contraindica-
tions to iodine contrast media including renal impair-
ment.12 Gadobutrol is a non-ionic gadolinium contrast
medium primarily intended for magnetic resonance
imaging, but it attenuates radiation photons as well. The
rationale should be that gadolinium-based contrast agents
appear approximately 20 times safer than iodinated agents
in patients with impaired renal function.13 However,
comparisons between gadolinium and iodine contrast
medium regarding CIN must be made at doses with both
equal-attenuating and equal-molecular doses, and gadoli-
nium contrast medium appears to be more nephrotoxic
than modern iodine contrast medium.14 Therefore, gadoli-
nium contrast medium should definitely not replace iodine
contrast medium in patients with impaired renal function.A 
Therapeutic intervention 
n = 48 
Bowel
resection 
n = 4  
Vascular intervention 
n = 43 
          1 (25%)         6 (75)      5 (83)         24 (83)
Endovascular
intervention 
n= 29* 
Hybrid 
intervention 
n = 6 ¤
Open
embolectomy 
n = 8#
occlusion in Malmo¨ 2005e2009. Hybrid means both open and
formed in five (62%)#, four (66%)¤ and five (17%)* patients,
730 S. Acosta et al.An early diagnosis by CT angiography and the develop-
ment of endovascular techniques have had a great impact
on survival of patients with acute SMA occlusion. The
clinician in charge needs to take full responsibility for the
patient and be very clear about the questions asked in
the referral letter for CT angiography. It is very important
to have a direct contact with the radiologist so that intra-
venous contrast is administrated despite an elevated
creatinine.1 The sometimes life-saving information gath-
ered from the CT angiography in various emergent abdom-
inal conditions should be weighed against the rather low
incidence of CIN3 and the often mild and transient forms.
In conclusion, serious acute CIN was not found in
patients diagnosed by CT angiography and treated by
endovascular procedures for acute SMA occlusion. Elevated
creatinine levels at admission, which was present in the
majority of study patients, should not deter the clinicians
from ordering a CT angiography in suspected cases.
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